<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01917292</url>
  </required_header>
  <id_info>
    <org_study_id>20130718emp</org_study_id>
    <secondary_id>31270992</secondary_id>
    <nct_id>NCT01917292</nct_id>
  </id_info>
  <brief_title>Impact of Periodontal Intervention on Vascular Dysfunction</brief_title>
  <official_title>Periodontal Intervention Improves Vascular Function Among Chinese Prehypertensive Adults With Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of periodontal intervention on vascular&#xD;
      dysfunction among Chinese prehypertensive adults with moderate to severe periodontal disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periodontitis is one of the low-grade chronic diseases, and it is the principal cause of&#xD;
      tooth loss among middle-aged and elderly. Recently, epidemiological data indicate that&#xD;
      patients with periodontitis are associated with increases in blood pressure levels and&#xD;
      hypertension prevalence. Furthermore, studies from cross-sectional investigations demonstrate&#xD;
      that hypertensive patients with periodontitis may enhance the risk and degree of vascular&#xD;
      damage. Therefore, periodontal therapy is a novel therapeutic strategy to prevent the&#xD;
      occurrence of BP elevation and retard the development vascular injury.&#xD;
&#xD;
      The term &quot;prehypertension&quot; indicates those with BPs ranging from 120 to 139 mm Hg systolic&#xD;
      and/or 80 to 89 mm Hg diastolic blood pressure. Accumulating evidence suggests that subjects&#xD;
      with prehypertension is associated with higher incidence of atherosclerotic vascular disease.&#xD;
      However, until now there are no available data to investigate the influence of periodontitis&#xD;
      on prehypertension and whether periodontal intervention may reduce the BP rise in subjects&#xD;
      with prehypertension and improve the vascular function. We hypothesized that periodontitis&#xD;
      leads to elevation in BP and periodontal therapy improves vascular function in subjects with&#xD;
      prehypertension. To address these assumptions, The present study is designed to study the&#xD;
      effect of periodontal intervention on blood pressure and vascular function and inflammatory&#xD;
      biomarkers among Chinese prehypertensive adults with moderate to severe periodontal disease,&#xD;
      and determine whether intensive periodontal therapy improves these measures over a 6-month&#xD;
      follow-up period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in the Number of Endothelial Microparticle at 6 months</measure>
    <time_frame>Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in the Blood Pressure at 6 months</measure>
    <time_frame>Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Brachia-ankle Pulse Wave Velocity(baPWV)</measure>
    <time_frame>Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in high-sensitivity C-Reactive Protein(hs-CRP) and Interleukin-6(IL-6)</measure>
    <time_frame>Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy</time_frame>
    <description>Compare the changes of traditional inflammatory biomarkersï¼šhs-CRP and IL-6 over a 6-month follow-up period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of the Long non-protein-coding RNA(lncRNA) and microRNA</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Malondialdehyde(MDA) and Superoxide Dismutase(SOD)</measure>
    <time_frame>Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Periodontal Inflamed Surface Area(PISA)</measure>
    <time_frame>Baseline; 3 months post periodontal therapy; 6 months post periodontal therapy</time_frame>
    <description>Bleeding on probing(BOP), clinical attachment loss (CAL) and gingival recession(GR) are measured to calculate the PISA.The PISA reflects the surface area of bleeding pocket epithelium in square millimetres.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Endothelium-dependent Brachial Artery Flow-mediated Dilation(FMD)</measure>
    <time_frame>Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Chronic Periodontitis</condition>
  <condition>Prehypertension</condition>
  <arm_group>
    <arm_group_label>Periodontal care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>One-Stage Full-Mouth Disinfection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One-Stage Full-Mouth Disinfection</intervention_name>
    <description>Basic oral hygiene instructions&#xD;
Dental extractions will be performed (only in cases of teeth that could not be saved)&#xD;
Standard cycle of supragingival ultrasonic scaling and polishing&#xD;
Scaling and root planning after the administration of local anesthesia, four quadrants in one session&#xD;
Minocycline Hydrochloride Ointment (Periocline, OraPharma) were delivered locally into the periodontal pockets</description>
    <arm_group_label>One-Stage Full-Mouth Disinfection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Periodontal care</intervention_name>
    <description>Basic oral hygiene instructions&#xD;
Standard cycle of supragingival ultrasonic scaling and polishing</description>
    <arm_group_label>Periodontal care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subjects must be 18 years of age or older&#xD;
&#xD;
          2. Moderate to severe generalized periodontitis(probing pocket depths of &gt;6 mm and&#xD;
             Marginal alveolar bone loss of &gt;30%) with 50% or more of their teeth affected&#xD;
&#xD;
          3. Have at least 16 natural teeth excluding third molars&#xD;
&#xD;
          4. BPs ranging from 120 to 139 mm Hg systolic and/or 80 to 89 mm Hg diastolic blood&#xD;
             pressure&#xD;
&#xD;
          5. Provide informed consent and willingness to cooperate with the study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of antibiotic use in the previous three months&#xD;
&#xD;
          2. Pregnant or lactating females&#xD;
&#xD;
          3. Systemic diseases such as diabetes, HIV/AIDS, liver disease, chronic renal failure,&#xD;
             tuberculosis, and autoimmune diseases&#xD;
&#xD;
          4. Medical history of cardiovascular disease: Acute myocardial infarct, stable angina,&#xD;
             unstable angina, heart failure, atrial fibrillation, atrioventricular blockade,&#xD;
             peripheral vascular disease, cerebrovascular accident, hypertension&#xD;
&#xD;
          5. Patients who received periodontal treatment within the last 6 months&#xD;
&#xD;
          6. Patients who require antibiotic prophylaxis before examination or treatment&#xD;
&#xD;
          7. Patients with mental retardation and dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun Ying Yang, Master</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun Tao, M.D.,phD.</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The First Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>August 1, 2013</study_first_submitted>
  <study_first_submitted_qc>August 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2013</study_first_posted>
  <last_update_submitted>April 15, 2015</last_update_submitted>
  <last_update_submitted_qc>April 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Junying Yang</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Periodontitis</keyword>
  <keyword>Prehypertension</keyword>
  <keyword>Periodontal Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
    <mesh_term>Prehypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

